Rare diseases
Investigational molecules
Locations
Back to Germany1 491 clinical trials in Frankfurt, Germany across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effects of ABBV-552 in Patients Aged 50-90 with Mild Alzheimer's Disease
GermanyStudy on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
GermanyStudy comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy
GermanyStudy on Ganaxolone for Children and Adults with Epilepsy Related to Tuberous Sclerosis Complex
GermanyStudy of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease
GermanyStudy on the Effectiveness and Safety of DBV712 for Peanut Allergy in Children Aged 4-7
GermanyStudy on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy
GermanyStudy Comparing Atezolizumab and Drug Combination with Pembrolizumab and Drug Combination for Patients with Advanced Lung Cancer
GermanyStudy of Magrolimab and Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Stem Cell Transplantation
GermanyStudy on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients
GermanyStudy on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Dystrophy After Cataract Surgery
GermanyStudy Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on hematologic malignancies and solid tumors, including innovative treatments for lymphoma, leukemia, and various gastrointestinal cancers.
Studies evaluate novel therapeutic combinations and targeted treatments to improve patient outcomes.
Research initiatives examining treatments for inflammatory bowel conditions, including Crohn's Disease and Ulcerative Colitis, with emphasis on long-term management approaches.
Focus on innovative therapeutic options for chronic inflammatory conditions.
Clinical investigations of treatments for rare conditions, including Von Willebrand Disease and Dravet Syndrome, exploring novel therapeutic approaches.
Development of targeted therapies for previously difficult-to-treat conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
